Browsing Over 180 Presentations

Sort By
YO Boxing session Young oncologist session

Should all breast cancer patients receiving AI be treated with bone-modifying agents regardless of age and baseline T-score? NO (ID 311)

Lecture Time
15:05 - 15:20
Speakers
Session Name
YO Boxing session
Room
Channel 3
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world Industry Satellite Symposia

From clinical trials to real-world effectiveness: Charting a new standard in HR+/HER2- breast cancer (ID 346)

Lecture Time
17:35 - 18:00
Speakers
Session Name
Pfizer Oncology - Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world
Room
Channel 1
Date
Thu, 06.05.2021
Time
17:30 - 18:30
Testing recommendation in breast cancer Educational session

State of art for luminal eBC: Ki67 and/or prognostic gene expression signatures? (ID 22)

Lecture Time
15:05 - 15:20
Speakers
Session Name
Testing recommendation in breast cancer
Room
Channel 3
Date
Sat, 08.05.2021
Time
15:00 - 16:15
Proffered Paper session 1 Proffered paper

Invited Discussant 63O and 91O (ID 241)

Lecture Time
14:36 - 14:46
Speakers
Session Name
Proffered Paper session 1
Room
Channel 2
Date
Fri, 07.05.2021
Time
14:15 - 15:30
Precision medicine in breast cancer Educational session

Is there a role for molecular profiling in early breast cancer? (ID 278)

Lecture Time
13:20 - 13:35
Speakers
Session Name
Precision medicine in breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
12:45 - 14:00
Optimal sequence in metastatic ER+ breast cancer Educational session

Q&A and live discussion (ID 306)

Lecture Time
16:50 - 17:00
Speakers
Session Name
Optimal sequence in metastatic ER+ breast cancer
Room
Channel 3
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer Industry Satellite Symposia

Improved patient outcomes with next-generation HER2-targeted ADCs (ID 341)

Lecture Time
16:20 - 16:35
Speakers
Session Name
Daiichi-Sankyo/AstraZeneca - ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer
Room
Channel 1
Date
Thu, 06.05.2021
Time
16:00 - 17:00
Breast cancer molecular tumor boards for the practicing oncologist: Ready for prime time? YO Virtual Lounge Discussions

Mentor (ID 380)

Lecture Time
11:00 - 12:00
Speakers
Session Name
Breast cancer molecular tumor boards for the practicing oncologist: Ready for prime time?
Room
Lounge
Date
Sat, 08.05.2021
Time
11:00 - 12:00
Immunotherapy in metastatic breast cancer (mBC) Educational session

First-line chemo-IO for mTNBC (ID 17)

Lecture Time
12:50 - 13:10
Speakers
Session Name
Immunotherapy in metastatic breast cancer (mBC)
Room
Channel 1
Date
Sat, 08.05.2021
Time
12:45 - 14:00
Best abstracts Proffered paper

Invited Discussant 41O, 42O and 43O (ID 236)

Lecture Time
17:52 - 18:07
Speakers
Session Name
Best abstracts
Room
Channel 1
Date
Fri, 07.05.2021
Time
17:15 - 18:30
Mini Oral session 2 Mini oral

Invited Discussant LBA1 and 96MO (ID 273)

Lecture Time
13:36 - 13:46
Speakers
Session Name
Mini Oral session 2
Room
Channel 2
Date
Sat, 08.05.2021
Time
12:45 - 14:00
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes Industry Satellite Symposia

Debating optimal neoadjuvant therapy (ID 336)

Lecture Time
19:30 - 19:40
Speakers
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00